We need something - SP is flagging and investor confidence in MSB is taking a hit. Other than the annual accounts which they had to announce they have been too quiet on progress for a company that is burning over $60m a year.
If they are now talking type II diabetes by end of the year you can pencil that in for well into next year, they haven't hit a deadline yet - so that's not going to help.
If DDD and Spinal Fusion are stuck in with FDA then they might not be out soon. CHF#3 is a mirage that lured us in and we would be foolish to expect much on that front.
Even the SP spruikers are starting to sound a bit shrill and disconcerted these days.
Sorry, feeling a bit disgruntled today.
disc, page-3
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.045(2.98%) |
Mkt cap ! $1.672B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.50 | $1.45 | $8.307M | 5.669M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 151320 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 55652 | 2 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |